GEN XXL GEAR
Home / Product Type / HGH & Peptides / Sexual Health Peptides

Category

Sexual Health Peptides

Lab Verified

Peptides targeting sexual health and function. Research-grade compounds including PT-141 (bremelanotide) and other wellness peptides.

6 Products
Buying Sexual Health Peptides Online

Buy Sexual Health Peptides Online - PT-141 and Wellness Compounds

Sexual health peptides address sexual function through central nervous system pathways rather than vascular mechanisms, offering a fundamentally different approach from traditional PDE5 inhibitors like sildenafil (Viagra) or tadalafil (Cialis). The most prominent compound in this category, PT-141 (bremelanotide), works by activating melanocortin receptors in the brain to increase sexual desire and arousal at the neurological level.

PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan II. Unlike Viagra and Cialis, which increase blood flow to achieve their effects, PT-141 acts on the central nervous system by binding to MC3R and MC4R melanocortin receptors in the hypothalamus. This mechanism means PT-141 addresses desire and arousal directly, not just the physical mechanics of performance. The FDA approved a version of bremelanotide (marketed as Vyleesi) for hypoactive sexual desire disorder in premenopausal women in 2019, making it one of the few peptides with direct clinical FDA approval for a specific condition.

For men, PT-141 has demonstrated effectiveness in research settings for improving sexual function, particularly in cases where PDE5 inhibitors alone have been insufficient. Because it works through a completely different pathway than Viagra or Cialis, it can be used as a standalone compound or in combination with PDE5 inhibitors for a dual-mechanism approach addressing both desire and vascular response.

Typical PT-141 dosing is 1 - 2 mg administered subcutaneously approximately 45 - 60 minutes before anticipated sexual activity. Effects can last 12 - 72 hours, with the peak occurring 2 - 4 hours after injection. Common side effects include mild nausea (usually only with the first use), flushing, and temporary darkening of skin - the latter due to melanocortin receptor activation, which also stimulates melanin production.

For users on anabolic steroid cycles, sexual health peptides serve as valuable support compounds. While testosterone and other AAS can enhance libido at moderate doses, high-dose cycles, trenbolone use, and PCT transitions can all impact sexual function. PT-141 provides on-demand support through these phases without affecting hormone levels or cycle parameters.

GenXXLGear carries research-grade PT-141 and other sexual health peptides from verified manufacturers. All products ship from our US warehouse in 3 - 6 business days. We accept Bitcoin, USDT, Zelle, and Visa.

Before you ask

Questions, answered

PT-141 (bremelanotide) works through the central nervous system by activating melanocortin receptors in the brain, directly increasing sexual desire and arousal. Viagra and Cialis work by increasing blood flow through PDE5 inhibition - they enhance the physical response but do not affect desire itself. PT-141 addresses the "wanting" component that vascular medications cannot.
Yes, PT-141 has been studied in both men and women. The FDA approved bremelanotide (as Vyleesi) specifically for hypoactive sexual desire disorder in premenopausal women. In men, it has shown effectiveness for improving sexual function and desire in research settings. Dosing is typically the same for both.
PT-141 is administered via subcutaneous injection approximately 45 - 60 minutes before anticipated activity. Peak effects occur 2 - 4 hours after injection, and its effects can persist for 12 - 72 hours depending on the individual. Unlike PDE5 inhibitors that are taken right before, PT-141 offers a longer window of activity.
The most common side effect is mild nausea, which typically occurs only with the first use and diminishes with subsequent doses. Some users experience flushing and temporary skin darkening due to melanocortin-driven melanin stimulation. Starting with a lower dose (0.5 - 1 mg) for the first administration can minimize nausea.
Yes, PT-141 works through an entirely different mechanism (CNS melanocortin receptors) than PDE5 inhibitors (vascular blood flow), so they can be combined. This dual approach addresses both desire/arousal and physical response simultaneously. GenXXLGear carries both PT-141 peptides and PDE5 inhibitors in our Pharmacy section, all shipping from our US warehouse.